Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1035

1.

Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock.

Samsky M, Krucoff M, Althouse AD, Abraham WT, Adamson P, Aguel F, Bilazarian S, Dangas GD, Gilchrist IC, Henry TD, Hochman JS, Kapur NK, Laschinger J, Masters RG, Michelson E, Morrow DA, Morrow V, Ohman EM, Pina I, Proudfoot AG, Rogers J, Sapirstein J, Senatore F, Stockbridge N, Thiele H, Truesdell AG, Waksman R, Rao S.

Am Heart J. 2019 Nov 7;219:1-8. doi: 10.1016/j.ahj.2019.10.006. [Epub ahead of print] Review. No abstract available.

PMID:
31707323
2.

Whole body periodic acceleration in normal and reduced mucociliary clearance of conscious sheep.

Sabater JR, Sackner MA, Adams JA, Abraham WM.

PLoS One. 2019 Nov 7;14(11):e0224764. doi: 10.1371/journal.pone.0224764. eCollection 2019.

3.

Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea: A Pooled Cohort Analysis.

Fudim M, Spector AR, Costanzo MR, Pokorney SD, Mentz RJ, Jagielski D, Augostini R, Abraham WT, Ponikowski PP, McKane SW, Piccini JP.

J Clin Sleep Med. 2019 Nov 5. pii: jc-19-00186. [Epub ahead of print]

PMID:
31685094
4.

The Tripeptide RER Mimics Secreted Amyloid Precursor Protein-Alpha in Upregulating LTP.

Morrissey JA, Bigus E, Necarsulmer JC, Srinivasan V, Peppercorn K, O'Leary DJ, Mockett BG, Tate WP, Hughes SM, Parfitt KD, Abraham WC.

Front Cell Neurosci. 2019 Oct 18;13:459. doi: 10.3389/fncel.2019.00459. eCollection 2019.

5.

Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea.

Fox H, Oldenburg O, Javaheri S, Ponikowski P, Augostini R, Goldberg LR, Stellbrink C, Mckane S, Meyer TE, Abraham WT, Costanzo MR.

Sleep. 2019 Oct 21;42(11). pii: zsz158. doi: 10.1093/sleep/zsz158.

6.

Losartan Rescues Inflammation-Related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis.

Kim MD, Baumlin N, Yoshida M, Polineni D, Salathe SF, David JK, Peloquin CA, Wanner A, Dennis JS, Sailland J, Whitney P, Horrigan FT, Sabater JR, Abraham WM, Salathe M.

Am J Respir Crit Care Med. 2019 Oct 15. doi: 10.1164/rccm.201905-0990OC. [Epub ahead of print]

PMID:
31613648
7.

Echocardiographic Outcomes after Transcatheter Leaflet Approximation in Patients with Secondary Mitral Regurgitation: The COAPT Trial.

Asch FM, Grayburn PA, Siegel RJ, Kar S, Lim DS, Zaroff JG, Mishell JM, Whisenant B, Mack MJ, Lindenfeld J, Abraham WT, Stone GW, Weissman NJ; COAPT Investigators.

J Am Coll Cardiol. 2019 Sep 28. pii: S0735-1097(19)37678-8. doi: 10.1016/j.jacc.2019.09.017. [Epub ahead of print]

8.

Tumor Necrosis Factor-α-Mediated Metaplastic Inhibition of LTP Is Constitutively Engaged in an Alzheimer's Disease Model.

Singh A, Jones OD, Mockett BG, Ohline SM, Abraham WC.

J Neurosci. 2019 Nov 13;39(46):9083-9097. doi: 10.1523/JNEUROSCI.1492-19.2019. Epub 2019 Sep 30.

PMID:
31570539
9.

Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.

Baron SJ, Wang K, Arnold SV, Magnuson EA, Whisenant B, Brieke A, Rinaldi M, Asgar AW, Lindenfeld J, Abraham WT, Mack MJ, Stone GW, Cohen DJ; COAPT Investigators.

Circulation. 2019 Dec 3;140(23):1881-1891. doi: 10.1161/CIRCULATIONAHA.119.043275. Epub 2019 Sep 29.

PMID:
31564137
10.

Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate.

Bergin DH, Jing Y, Williams G, Mockett BG, Zhang H, Abraham WC, Liu P.

Sci Rep. 2019 Sep 3;9(1):12669. doi: 10.1038/s41598-019-49078-0.

11.

Secreted Amyloid Precursor Protein-Alpha Promotes Arc Protein Synthesis in Hippocampal Neurons.

Livingstone RW, Elder MK, Barrett MC, Westlake CM, Peppercorn K, Tate WP, Abraham WC, Williams JM.

Front Mol Neurosci. 2019 Aug 14;12:198. doi: 10.3389/fnmol.2019.00198. eCollection 2019.

12.

Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial.

Singh JP, Abraham WT, Auricchio A, Delnoy PP, Gold M, Reddy VY, Sanders P, Lindenfeld J, Rinaldi CA.

Am Heart J. 2019 Nov;217:13-22. doi: 10.1016/j.ahj.2019.04.002. Epub 2019 Apr 9.

13.

Initial Experience with the Second-Generation V-Wave Shunt for Treating Patients with Chronic Heart Failure.

Guimarães L, Bergeron S, Bernier M, Rodriguez-Gabella T, Del Val D, Pibarot P, Eigler N, Abraham WT, Rodés-Cabau J.

EuroIntervention. 2019 Aug 20. pii: EIJ-D-19-00291. doi: 10.4244/EIJ-D-19-00291. [Epub ahead of print] No abstract available.

14.

Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development.

Psotka MA, Fiuzat M, Carson PE, Kao DP, Cerkvenik J, Schaber DE, Verta P, Kazmierski RT, Shinnar M, Stockbridge N, Unger EF, Zuckerman B, Butler J, Felker GM, Konstam MA, Lindenfeld J, Solomon SD, Teerlink JR, O'Connor CM, Abraham WT.

JACC Heart Fail. 2019 Nov;7(11):913-921. doi: 10.1016/j.jchf.2019.07.001. Epub 2019 Aug 7. Review.

15.

Gloeosporiocide, a new antifungal cyclic peptide from Streptomyces morookaense AM25 isolated from the Amazon bulk soil.

Vicente Dos Reis G, Abraham WR, Grigoletto DF, de Campos JB, Marcon J, da Silva JA, Quecine MC, de Azevedo JL, Ferreira AG, de Lira SP.

FEMS Microbiol Lett. 2019 Jul 1;366(14). pii: fnz175. doi: 10.1093/femsle/fnz175.

PMID:
31390020
16.

Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor.

Ma L, Dichwalkar T, Chang JYH, Cossette B, Garafola D, Zhang AQ, Fichter M, Wang C, Liang S, Silva M, Kumari S, Mehta NK, Abraham W, Thai N, Li N, Wittrup KD, Irvine DJ.

Science. 2019 Jul 12;365(6449):162-168. doi: 10.1126/science.aav8692.

17.

Is plasticity of synapses the mechanism of long-term memory storage?

Abraham WC, Jones OD, Glanzman DL.

NPJ Sci Learn. 2019 Jul 2;4:9. doi: 10.1038/s41539-019-0048-y. eCollection 2019. Review.

18.

Link between Heterotrophic Carbon Fixation and Virulence in the Porcine Lung Pathogen Actinobacillus pleuropneumoniae.

Konze SA, Abraham WR, Goethe E, Surges E, Kuypers MMM, Hoeltig D, Meens J, Vogel C, Stiesch M, Valentin-Weigand P, Gerlach GF, Buettner FFR.

Infect Immun. 2019 Aug 21;87(9). pii: e00768-18. doi: 10.1128/IAI.00768-18. Print 2019 Sep.

PMID:
31285248
19.

Health care utilization and mortality associated with heart failure-related admissions among cancer patients.

Guha A, Dey AK, Armanious M, Dodd K, Bonsu J, Jneid H, Abraham W, Fradley MG, Addison D.

ESC Heart Fail. 2019 Aug;6(4):733-746. doi: 10.1002/ehf2.12450. Epub 2019 Jul 2.

20.

Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure.

Abraham WT, Ponikowski P, Brueckmann M, Zeller C, Macesic H, Peil B, Brun M, Ustyugova A, Jamal W, Salsali A, Lindenfeld J, Anker SD; EMPERIAL Investigators and National Coordinators.

Eur J Heart Fail. 2019 Jul;21(7):932-942. doi: 10.1002/ejhf.1486. Epub 2019 Jun 19.

21.

A C-terminal peptide from secreted amyloid precursor protein-α enhances long-term potentiation in rats and a transgenic mouse model of Alzheimer's disease.

Morrissey JA, Mockett BG, Singh A, Kweon D, Ohline SM, Tate WP, Hughes SM, Abraham WC.

Neuropharmacology. 2019 Oct;157:107670. doi: 10.1016/j.neuropharm.2019.107670. Epub 2019 Jun 13.

PMID:
31202608
22.

Electronic Cigarette Vapor with Nicotine Causes Airway Mucociliary Dysfunction Preferentially via TRPA1 Receptors.

Chung S, Baumlin N, Dennis JS, Moore R, Salathe SF, Whitney PL, Sabater J, Abraham WM, Kim MD, Salathe M.

Am J Respir Crit Care Med. 2019 Nov 1;200(9):1134-1145. doi: 10.1164/rccm.201811-2087OC.

PMID:
31170808
23.

Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF).

Lindenfeld J, Abraham WT, Maisel A, Zile M, Smart F, Costanzo MR, Mehra MR, Ducharme A, Sears SF, Desai AS, Paul S, Sood P, Johnson N, Ginn G, Adamson PB.

Am Heart J. 2019 Aug;214:18-27. doi: 10.1016/j.ahj.2019.04.014. Epub 2019 May 3. No abstract available.

24.

Too Different or Too Late?: Gender Differences in Outcomes After Mitral Valve Surgery.

Lampert BC, Lindenfeld J, Abraham WT.

JACC Heart Fail. 2019 Jun;7(6):491-492. doi: 10.1016/j.jchf.2019.03.015. No abstract available.

PMID:
31146873
25.

Apneas of Heart Failure and Phenotype-Guided Treatments: Part One: OSA.

Javaheri S, Brown LK, Abraham WT, Khayat R.

Chest. 2019 Apr 29. pii: S0012-3692(19)30888-8. doi: 10.1016/j.chest.2019.02.407. [Epub ahead of print] Review.

PMID:
31047953
26.

Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.

Piccini JP, Abraham WT, Dufton C, Carroll IA, Healey JS, van Veldhuisen DJ, Sauer WH, Anand IS, White M, Wilton SB, Aleong R, Rienstra M, Krueger SK, Ayala-Paredes F, Khaykin Y, Merkely B, Miloradović V, Wranicz JK, Ilkhanoff L, Ziegler PD, Davis G, Emery LL, Marshall D, Kao DP, Bristow MR, Connolly SJ; GENETIC-AF Trial Investigators.

JACC Heart Fail. 2019 Jul;7(7):586-598. doi: 10.1016/j.jchf.2019.04.004. Epub 2019 Apr 29.

PMID:
31042551
27.

Phrenic nerve stimulation in patients with central sleep apnea: a single‑center experience from pilot and pivotal trials evaluating the remedē System.

Jagielski D, Kołodziej A, Westlund R, Biel B, Nowak K, Szemplińska I, Flinta I, Krawczyk M, Kulej K, Krakowiak B, Germany R, Panteleon A, McKane S, Banasiak W, Abraham WT, Ponikowski P.

Kardiol Pol. 2019 May 24;77(5):553-560. doi: 10.5603/KP.a2019.0061. Epub 2019 Apr 9.

28.

Establishment of an induced memory response in Pseudomonas aeruginosa during infection of a eukaryotic host.

Kordes A, Grahl N, Koska M, Preusse M, Arce-Rodriguez A, Abraham WR, Kaever V, Häussler S.

ISME J. 2019 Aug;13(8):2018-2030. doi: 10.1038/s41396-019-0412-1. Epub 2019 Apr 5.

PMID:
30952997
29.

Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.

Arnold SV, Chinnakondepalli KM, Spertus JA, Magnuson EA, Baron SJ, Kar S, Lim DS, Mishell JM, Abraham WT, Lindenfeld JA, Mack MJ, Stone GW, Cohen DJ; COAPT Investigators.

J Am Coll Cardiol. 2019 May 7;73(17):2123-2132. doi: 10.1016/j.jacc.2019.02.010. Epub 2019 Mar 17.

PMID:
30894288
30.

Imaging Device Therapy: Essentials for the Imager.

Harfi TT, Milks MW, Orsinelli DA, Raman SV, Abraham WT, Kahwash R.

Heart Fail Clin. 2019 Apr;15(2):305-320. doi: 10.1016/j.hfc.2018.12.011. Epub 2019 Feb 10. Review.

PMID:
30832820
31.

Glutamate Receptor Trafficking and Protein Synthesis Mediate the Facilitation of LTP by Secreted Amyloid Precursor Protein-Alpha.

Mockett BG, Guévremont D, Elder MK, Parfitt KD, Peppercorn K, Morrissey J, Singh A, Hintz TJ, Kochen L, Tom Dieck S, Schuman E, Tate WP, Williams JM, Abraham WC.

J Neurosci. 2019 Apr 24;39(17):3188-3203. doi: 10.1523/JNEUROSCI.1826-18.2019. Epub 2019 Feb 25.

32.

Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.

Mann JA, Abraham WT.

Curr Heart Fail Rep. 2019 Feb;16(1):38-46. doi: 10.1007/s11897-019-0422-3. Review.

PMID:
30762177
33.

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis.

Dewan P, Rørth R, Jhund PS, Ferreira JP, Zannad F, Shen L, Køber L, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators.

JACC Heart Fail. 2019 Apr;7(4):336-346. doi: 10.1016/j.jchf.2018.11.005. Epub 2019 Feb 6.

34.

Electrophysiological Investigation of Metabotropic Glutamate Receptor-Dependent Metaplasticity in the Hippocampus.

Hegemann RU, Abraham WC.

Methods Mol Biol. 2019;1941:79-91. doi: 10.1007/978-1-4939-9077-1_7.

PMID:
30707429
35.

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women.

Dewan P, Rørth R, Jhund PS, Shen L, Raparelli V, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Mogensen UM, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV.

J Am Coll Cardiol. 2019 Jan 8;73(1):29-40. doi: 10.1016/j.jacc.2018.09.081.

36.

Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: the HEMO-VAD pilot study.

Veenis JF, Manintveld OC, Constantinescu AA, Caliskan K, Birim O, Bekkers JA, van Mieghem NM, den Uil CA, Boersma E, Lenzen MJ, Zijlstra F, Abraham WT, Adamson PB, Brugts JJ.

ESC Heart Fail. 2019 Feb;6(1):194-201. doi: 10.1002/ehf2.12392. Epub 2019 Jan 7.

37.

A Novel Wireless Left Atrial Pressure Monitoring System for Patients with Heart Failure, First Ex-Vivo and Animal Experience.

Perl L, Soifer E, Bartunek J, Erdheim D, Köhler F, Abraham WT, Meerkin D.

J Cardiovasc Transl Res. 2019 Aug;12(4):290-298. doi: 10.1007/s12265-018-9856-3. Epub 2019 Jan 2.

PMID:
30604310
38.

Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.

Dewan P, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Køber L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS Jr, Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV.

Eur J Heart Fail. 2019 May;21(5):577-587. doi: 10.1002/ejhf.1347. Epub 2018 Dec 10.

39.

Genetic targeting and chemogenetic inhibition of new born neurons.

Schoderboeck L, Wicky HE, Abraham WC, Hughes S.

Hum Gene Ther Methods. 2018 Dec 7. doi: 10.1089/hgtb.2018.182. [Epub ahead of print]

PMID:
30526082
40.

Ambulatory Fontan pressure monitoring: Results from the implantable hemodynamic monitor Fontan feasibility cohort (IHM-FFC).

Bradley EA, Jassal A, Moore-Clingenpeel M, Abraham WT, Berman D, Daniels CJ.

Int J Cardiol. 2019 Jun 1;284:22-27. doi: 10.1016/j.ijcard.2018.10.081. Epub 2018 Oct 28.

PMID:
30420147
41.

Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.

Rodés-Cabau J, Bernier M, Amat-Santos IJ, Ben Gal T, Nombela-Franco L, García Del Blanco B, Kerner A, Bergeron S, Del Trigo M, Pibarot P, Shkurovich S, Eigler N, Abraham WT.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2300-2310. doi: 10.1016/j.jcin.2018.07.001. Epub 2018 Nov 1.

42.

Cytochalasans Act as Inhibitors of Biofilm Formation of Staphylococcus Aureus.

Yuyama KT, Wendt L, Surup F, Kretz R, Chepkirui C, Wittstein K, Boonlarppradab C, Wongkanoun S, Luangsa-Ard J, Stadler M, Abraham WR.

Biomolecules. 2018 Oct 30;8(4). pii: E129. doi: 10.3390/biom8040129.

43.

Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.

Parikh KS, Fiuzat M, Davis G, Neely M, Blain-Nelson P, Whellan DJ, Abraham WT, Adams KF Jr, Felker GM, Liggett SB, O'Connor CM, Bristow MR.

Circ Genom Precis Med. 2018 Aug;11(8):e002210. doi: 10.1161/CIRCGEN.117.002210.

44.

Circulating Plasma microRNAs are Altered with Amyloidosis in a Mouse Model of Alzheimer's Disease.

Ryan MM, Guévremont D, Mockett BG, Abraham WC, Williams JM.

J Alzheimers Dis. 2018;66(2):835-852. doi: 10.3233/JAD-180385.

PMID:
30347618
45.

Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure.

Costanzo MR, Ponikowski P, Coats A, Javaheri S, Augostini R, Goldberg LR, Holcomb R, Kao A, Khayat RN, Oldenburg O, Stellbrink C, McKane S, Abraham WT; remedē® System Pivotal Trial Study Group.

Eur J Heart Fail. 2018 Dec;20(12):1746-1754. doi: 10.1002/ejhf.1312. Epub 2018 Oct 10.

46.

Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ; COAPT Investigators.

N Engl J Med. 2018 Dec 13;379(24):2307-2318. doi: 10.1056/NEJMoa1806640. Epub 2018 Sep 23.

PMID:
30280640
47.

From Synaptic Metaplasticity to Behavioral Metaplasticity.

Abraham WC, Richter-Levin G.

Neurobiol Learn Mem. 2018 Oct;154:1-4. doi: 10.1016/j.nlm.2018.08.015. No abstract available.

PMID:
30217268
48.

Environmental enrichment increases prefrontal EEG power and synchrony with the hippocampus in rats with anterior thalamus lesions.

Ulrich K, Spriggs MJ, Abraham WC, Dalrymple-Alford JC, McNaughton N.

Hippocampus. 2019 Feb;29(2):128-140. doi: 10.1002/hipo.23022. Epub 2018 Nov 22.

PMID:
30153381
49.

Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.

Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, Kapadia SR, McCarthy PM, Lim DS, Udelson JE, Zile MR, Gammie JS, Gillinov AM, Glower DD, Heimansohn DA, Suri RM, Ellis JT, Shu Y, Kar S, Weissman NJ, Stone GW.

Am Heart J. 2018 Nov;205:1-11. doi: 10.1016/j.ahj.2018.07.021. Epub 2018 Aug 1.

PMID:
30134187
50.

First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF.

Zile MR, Abraham WT, Lindenfeld J, Weaver FA, Zannad F, Graves T, Rogers T, Galle EG.

Am Heart J. 2018 Oct;204:139-150. doi: 10.1016/j.ahj.2018.07.011. Epub 2018 Jul 22.

Supplemental Content

Loading ...
Support Center